Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
FDA Approval: The FDA branded medications containing semaglutide and tirzepatide are approved for chronic weight management, while compounded formulations are not FDA-approved for this specific use
At NY Medical Weight Loss, we are committed to providing our patients with up-to-date information about weight management options, including Semaglutidea GLP-1 receptor agonist prescribed for both type 2 diabetes and weight loss
Mary Frances McCullar, 49, started taking a compounded version of semaglutide on January 4 2023 and lost 21 pounds in the first 10 weeks
A complete metabolic panel will be drawn prior to starting the program
US$ 24.97
US$ 27.13
US$ 27.27
US$ 29.69
US$ 24.47
US$ 20.90
US$ 20.53
US$ 26.09
US$ 29.78
US$ 29.02
